← Compound index
RESEARCH FAMILY / LIBEROL

Liberol / TRH researchЛиберол

A historical Russian buccal-film formulation of thyrotropin-releasing hormone (TRH, or thyroliberin), the tripeptide pGlu–His–Pro–NH₂.

PerformanceStress
Source linked

What the studies found

Study involving people · 2003

Liberol in simulated altitude and exercise

Simulated altitude ceiling
7.0 → 7.5 kmAuthor-reported altitude tolerance.
Reported time reserve in hypoxia
850 → 950 sThe conclusions describe simulated altitudes of 5–8 km.
Muscular endurance
+28–39%Author-reported range. Group-level tables are unavailable.

Padalko’s dissertation reports five experimental series in humans.

More reported outcomes
Vestibular symptoms
24–26% lower severityAutonomic and sensory symptoms after motion stress.
Study notes · methods, sources and limitations

Participants or model Human occupational experiments; dissertation transcription

Design Five experimental series: simulated altitude, vestibular loading, exercise, operator tasks and biochemical responses. The dissertation attributes the work to three military medicine research projects, six methodological documents and ten publications.

Important limitations

  • Full group tables, allocation and the experimental dose remain unverified.
  • The checked conclusions do not establish group sizes, allocation, precise dose or the size of a controlled treatment effect. Endocrine and adverse-event monitoring require the original tables.
  • The numerical claims are traceable to the dissertation conclusions. They add no participant records because the underlying cohorts and their sizes remain unverified.

Primary source linked above · Publication record

Original source or citation ↗

Study results and tables ↗
01 / OVERVIEW

About Liberol / TRH research

Names in this research collection

TRH · Protirelin · Thyrotropin releasing hormone · Padalko

Research background

An archival occupational-research record for the Liberol/TRH branch, covering historical human functional-reserve experiments.

Archival sources and remaining questions ↗

Historical Liberol formulation

Russian Ministry of Health Order No. 368 registered Liberol as a prescription buccal polymer film containing TRH (pGlu–His–Pro–NH₂), registration 96/368/4. The historical label describes short-term treatment of asthenodepressive and related conditions and lists transient blood pressure elevation, flushing and faster breathing. The historical label does not establish the dose used in the 2003 performance experiments.

Japan’s PMDA lists Hirtonin as an injectable protirelin tartrate formulation. Its route and formulation differ from the Russian film. PMDA product record ↗

1996 registration and historical label ↗ · Dissertation and military archive ↗

Compound class
Peptide research family
Research collection
Neuropeptide research · editorial grouping
Institutions in linked studies
See individual study records
Source review
Review dates and the material assessed are listed with each publication below.
02 / HOW TO READ THE RESEARCH

Understanding the evidence

Human research

Human dissertation material; original scan and study design pending

Study methods

Member-specific studies; patents and archival leads identified separately

Independent replication

Independent replication not established by the records collected here

Source access

Primary abstracts, selected full texts, patents and explicit retrieval targets

Safety evidence

Cell and animal effects do not establish human safety; analogues may differ

Open a topic for the evidence assessment.

More findings, background and history
IDENTITY / MEMBER-SPECIFIC EVIDENCE

Inside this research family

Grouping supports navigation. It does not imply equivalent composition, mechanisms, effectiveness or safety.

Research objects, findings and source boundaries
MemberIdentityWhat the source supports
LiberolTRH/protirelin identification trail

The dissertation identifies Liberol as thyroliberin/TRH, pGlu–His–Pro–NH₂; formulation details still need original-scan review.

Use of the peptide bioregulator Liberol to restore human functional reserves under extreme exposures ↗

Occupational experimentsHypoxia, motion stress and performance

Human dissertation material; allocation and full numerical tables remain under review.

Use of the peptide bioregulator Liberol to restore human functional reserves under extreme exposures ↗

Interpretation and open questions

Historical functional-reserve experiments do not establish protection during real-world altitude exposure or dangerous work.

Explore the Russian peptide research map ↗

What remains unclear

The Russian State Library catalogue lists Padalko’s 117-page dissertation under 01004306643. Its methods, allocation, safety and preparation identity require confirmation from the original.

Human reports are linked; their presence does not establish effectiveness. Several publications can describe the same participants.

Browse original study records ↗
03 / SOURCE RECORDS

Findings by study

Explore related research ↗

Study involving people · 2003

Use of the peptide bioregulator Liberol to restore human functional reserves under extreme exposures

Padalko’s dissertation reports five experimental series in humans.

Simulated altitude ceiling · 7.0 → 7.5 km · Author-reported altitude tolerance.

Study notes and original source
2003Human study · design details unresolvedRussian-language source

Use of the peptide bioregulator Liberol to restore human functional reserves under extreme exposures

S. V. Padalko · Primary source linked above

Padalko reports a simulated altitude ceiling of 7.0 to 7.5 km and hypoxia reserve time of 850 to 950 seconds after Liberol. The conclusions do not supply group-level tables.

Results and tables

Reported findings and study design

Five experimental series: simulated altitude, vestibular loading, exercise, operator tasks and biochemical responses. The dissertation attributes the work to three military medicine research projects, six methodological documents and ten publications.

Population or model Human occupational experiments; dissertation transcription

Results · Dissertation methods outline, conclusions and Russian State Library catalogue. Full group tables unavailable.
MeasureResultComparison, timing and statistics
Simulated altitude ceiling7.0 → 7.5 kmAuthor-reported altitude tolerance.
Reported time reserve in hypoxia850 → 950 sThe conclusions describe simulated altitudes of 5–8 km.
Muscular endurance+28–39%Author-reported range. Group-level tables are unavailable.
Vestibular symptoms24–26% lower severityAutonomic and sensory symptoms after motion stress.
Auditory reflexShorter acoustic-reflex latency after a single exposureThe dissertation reports slower auditory synaptic transmission after repeated administration.
Simulated altitude and cognitionHigher mental work capacity describedNo effect on decompression disturbances reported under the tested conditions.

The numerical claims are traceable to the dissertation conclusions. They add no participant records because the underlying cohorts and their sizes remain unverified.

Source for these results ↗ · Reviewed 2026-11-17

Population / setting
Human occupational experiments; dissertation transcription
Source reviewed
Dissertation methods outline, conclusions and Russian State Library catalogue. Full group tables unavailable.
Study limitations
  • The checked conclusions do not establish group sizes, allocation, precise dose or the size of a controlled treatment effect.
  • Endocrine and adverse-event monitoring require the original tables.

Reviewed 2026-11-17.

Read the source ↗

Follow shared publications or research classes. These links do not establish equivalent effects between compounds.

Research collection curated by @PepMariner · editorial standards. Send a source correction ↗

Browse bibliography & PDFs ↗